Review of the Pathologic Characteristics in Myhre Syndrome: Gain-of-Function Pathogenic Variants in SMAD4 cause a Multisystem Fibroproliferative Response.
Lois Janelle StarrMark E LindsayDeborah PerryGregory GheewallaPaul A VanderLaanAdnan MajidCharlie StrangeGeorge-Claudiu CosteaAdrian LunguAngela E LinPublished in: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society (2022)
Background: Myhre syndrome, caused by pathogenic variants in SMAD4 , is characterized by compact body habitus with short stature, distinctive craniofacial appearance, stiff skin, cardiovascular abnormalities (valve stenosis, coarctation, hypoplasia, or stenosis of aorta), effusions of potential spaces (pericardium, pleura, peritoneum), restricted movement of the joints (including thorax), and hearing loss. Lung and airway disease has been reported, but not always well-defined, to include interstitial lung disease, large airway obstruction, and pulmonary arterial hypertension. Excessive fibroproliferation of tissues especially following trauma or surgical instrumentation has been recognized, although these may also present spontaneously. Method: We report the pathologic features of 1 new patient with progressive choanal stenosis, and 22 literature cases, including the expanded history of 5 patients (3 who died). Results: Examination of patient tissues documents cellular fibroproliferation and deposition of excessive extracellular matrix explaining some of the observed clinical features of Myhre syndrome. Conclusion: Excessive fibrosis is noted in multiple tissues, especially heart, lung, and upper and lower airways. Our research provides the first systematic review to provide a knowledge base of gross and pathologic findings in Myhre syndrome.
Keyphrases
- case report
- systematic review
- pulmonary arterial hypertension
- extracellular matrix
- interstitial lung disease
- neoadjuvant chemotherapy
- pulmonary artery
- gene expression
- weight gain
- aortic valve
- pulmonary hypertension
- multiple sclerosis
- healthcare
- epithelial mesenchymal transition
- rheumatoid arthritis
- heart failure
- copy number
- randomized controlled trial
- transforming growth factor
- meta analyses
- coronary artery disease
- body mass index
- coronary artery
- signaling pathway
- lymph node
- weight loss
- low cost